{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T01:21:25Z","timestamp":1775265685885,"version":"3.50.1"},"reference-count":18,"publisher":"Walter de Gruyter GmbH","issue":"4","license":[{"start":{"date-parts":[[2018,10,20]],"date-time":"2018-10-20T00:00:00Z","timestamp":1539993600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,12,19]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec id=\"j_pp-2018-0122_s_011_w2aab3b7b1b1b6b1aab1c16b1Aa\">\n                    <jats:title id=\"d1045279e395_w2aab3b7b1b1b6b1aab1c16b1aAa\">Background<\/jats:title>\n                    <jats:p>Cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) is routinely used for selected patients with peritoneal metastasis, but can be associated with high complication rates, prolonged hospital stay, and mortality. Our objective was to determine the learning curve of CRS\/HIPEC in our institution, representing the largest Asian cohort to date.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_pp-2018-0122_s_012_w2aab3b7b1b1b6b1aab1c16b2Aa\">\n                    <jats:title id=\"d1045279e404_w2aab3b7b1b1b6b1aab1c16b2aAa\">Methods<\/jats:title>\n                    <jats:p>A total of 200 consecutive patients with peritoneal metastasis treated with CRS\/HIPEC between 2001 and 2016 were grouped into four cohorts of 50 patients and studied. Primary outcomes were severe morbidity (Clavien-Dindo III-V), procedure-related mortality, and duration of ICU and hospital stays. Secondary outcome was duration of surgery.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_pp-2018-0122_s_013_w2aab3b7b1b1b6b1aab1c16b3Aa\">\n                    <jats:title id=\"d1045279e413_w2aab3b7b1b1b6b1aab1c16b3aAa\">Results<\/jats:title>\n                    <jats:p>Median age was 53 years (10\u201375). There was no significant age, sex, or histology difference across cohorts. Rates of severe morbidity (23\u2006%), and 60 day inpatient mortality (0.5\u2006%) were comparable to previously reported data. Decreases in rates of serious morbidity, (34\u2006%, 30\u2006%, 12\u2006%, 14\u2006%, p&lt;0.01) and duration of total hospital stay (14, 16, 13, 12 days, p=0.041) were seen across consecutive cohorts. Operation time decreased significantly after the first cohort (10, 7.8, 7.8, 7.2\u2006h, p&lt;0.01), despite increase in average PCI score after the first cohort (8, 14, 12, 13, p=0.063).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_pp-2018-0122_s_014_w2aab3b7b1b1b6b1aab1c16b4Aa\">\n                    <jats:title id=\"d1045279e422_w2aab3b7b1b1b6b1aab1c16b4aAa\">Conclusions<\/jats:title>\n                    <jats:p>Whilst 50 cases were adequate for procedural familiarity and decreased average operation time, significant improvement in rate of serious morbidity was observed after 100 operations. We demonstrate a novel biphasic nature to the learning curve, reflecting initial training in which technical competence is achieved, followed by a subsequent period characterized by increasingly complex cases (higher PCI score) and finally refinement of patient selection.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1515\/pp-2018-0122","type":"journal-article","created":{"date-parts":[[2018,10,23]],"date-time":"2018-10-23T05:04:48Z","timestamp":1540271088000},"source":"Crossref","is-referenced-by-count":11,"title":["Biphasic learning curve of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy:technical competence and refinement of patient selection"],"prefix":"10.1515","volume":"3","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8742-8285","authenticated-orcid":false,"given":"Nicholas B","family":"Shannon","sequence":"first","affiliation":[{"name":"Singapore General Hospital , Singapore"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Grace Hwei Ching","family":"Tan","sequence":"additional","affiliation":[{"name":"Division of Surgical Oncology , National Cancer Centre Singapore , Singapore"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claramae Shulyn","family":"Chia","sequence":"additional","affiliation":[{"name":"Division of Surgical Oncology , National Cancer Centre Singapore , Singapore"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khee Chee","family":"Soo","sequence":"additional","affiliation":[{"name":"Division of Surgical Oncology , National Cancer Centre Singapore , Singapore"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melissa Ching Ching","family":"Teo","sequence":"additional","affiliation":[{"name":"Division of Surgical Oncology , National Cancer Centre Singapore , 11 Hospital Drive, Singapore 169610, Singapore"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"374","published-online":{"date-parts":[[2018,10,20]]},"reference":[{"key":"2025120909201194912_j_pp-2018-0122_ref_001_w2aab3b7b1b1b6b1ab1b6b1Aa","doi-asserted-by":"crossref","unstructured":"Kuijpers AM, Mirck B, Aalbers AG, Nienhuijs SW, de Hingh IH, Wiezer MJ, et al. Cytoreduction and HIPEC in The Netherlands: nationwide long-term outcome following the Dutch protocol. Ann Surg Oncol. 2013;20:4224\u201330.10.1245\/s10434-013-3145-923897008","DOI":"10.1245\/s10434-013-3145-9"},{"key":"2025120909201194912_j_pp-2018-0122_ref_002_w2aab3b7b1b1b6b1ab1b6b2Aa","doi-asserted-by":"crossref","unstructured":"Spiliotis J, Halkia E, Lianos E, Kalantzi N, Grivas A, Efstathiou E, et al. Cytoreductive surgery and HIPEC in recurrent epithelial ovarian cancer: a prospective randomized phase III study. Ann Surg Oncol. 2015;22:1570\u201375.10.1245\/s10434-014-4157-925391263","DOI":"10.1245\/s10434-014-4157-9"},{"key":"2025120909201194912_j_pp-2018-0122_ref_003_w2aab3b7b1b1b6b1ab1b6b3Aa","doi-asserted-by":"crossref","unstructured":"Sugarbaker PH, Chang D. Results of treatment of 385 patients with peritoneal surface spread of appendiceal malignancy. Ann Surg Oncol. 1999;6:727\u201331.10.1007\/s10434-999-0727-710622499","DOI":"10.1007\/s10434-999-0727-7"},{"key":"2025120909201194912_j_pp-2018-0122_ref_004_w2aab3b7b1b1b6b1ab1b6b4Aa","doi-asserted-by":"crossref","unstructured":"Yan TD, Deraco M, Baratti D, Kusamura S, Elias D, Glehen O, et al. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for malignant peritoneal mesothelioma: multi-institutional experience. J Clin Oncol. 2009;27:6237\u201342.10.1200\/JCO.2009.23.964019917862","DOI":"10.1200\/JCO.2009.23.9640"},{"key":"2025120909201194912_j_pp-2018-0122_ref_005_w2aab3b7b1b1b6b1ab1b6b5Aa","doi-asserted-by":"crossref","unstructured":"Chia CS, Tan GH, Lim C, Soo KC, Teo MC. Prospective quality of life study for colorectal cancer patients with peritoneal carcinomatosis undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Ann Surg Oncol. 2016 March: 13\u201315. DOI:10.1245\/s10434-016-5203-6.","DOI":"10.1245\/s10434-016-5203-6"},{"key":"2025120909201194912_j_pp-2018-0122_ref_006_w2aab3b7b1b1b6b1ab1b6b6Aa","doi-asserted-by":"crossref","unstructured":"Chua TC, Yan TD, Saxena A, Morris DL. Should the treatment of peritoneal carcinomatosis by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy still be regarded as a highly morbid procedure?: a systematic review of morbidity and mortality. Ann Surg. 2009;249:900\u201307.10.1097\/SLA.0b013e3181a45d8619474692","DOI":"10.1097\/SLA.0b013e3181a45d86"},{"key":"2025120909201194912_j_pp-2018-0122_ref_007_w2aab3b7b1b1b6b1ab1b6b7Aa","doi-asserted-by":"crossref","unstructured":"Murphy EM, Sexton R, Moran BJ. Early results of surgery in 123 patients with pseudomyxoma peritonei from a perforated appendiceal neoplasm. Dis Colon Rectum. 2007;50:37\u201342.10.1007\/s10350-006-0741-917115339","DOI":"10.1007\/s10350-006-0741-9"},{"key":"2025120909201194912_j_pp-2018-0122_ref_008_w2aab3b7b1b1b6b1ab1b6b8Aa","doi-asserted-by":"crossref","unstructured":"Elias D, Honor\u00e9 C, Ciuchend\u00e9a R, Billard V, Raynard B, Lo Dico R, et al. Peritoneal pseudomyxoma: results of a systematic policy of complete cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Br J Surg. 2008;95:1164\u201371.10.1002\/bjs.623518690633","DOI":"10.1002\/bjs.6235"},{"key":"2025120909201194912_j_pp-2018-0122_ref_009_w2aab3b7b1b1b6b1ab1b6b9Aa","doi-asserted-by":"crossref","unstructured":"Mohamed F, Moran BJ. Morbidity and mortality with cytoreductive surgery and intraperitoneal chemotherapy: the importance of a learning curve. Cancer J. 2009;15:196\u201399.1955690410.1097\/PPO.0b013e3181a58d56","DOI":"10.1097\/PPO.0b013e3181a58d56"},{"key":"2025120909201194912_j_pp-2018-0122_ref_010_w2aab3b7b1b1b6b1ab1b6c10Aa","doi-asserted-by":"crossref","unstructured":"Loungnarath R, Causeret S, Bossard N, Faheez M, Sayag-Beaujard AC, Brigand C, et al. Cytoreductive surgery with intraperitoneal chemohyperthermia for the treatment of pseudomyxoma peritonei: a prospective study. Dis Colon Rectum. 2005;48:1372\u201379.1590907110.1007\/s10350-005-0045-5","DOI":"10.1007\/s10350-005-0045-5"},{"key":"2025120909201194912_j_pp-2018-0122_ref_011_w2aab3b7b1b1b6b1ab1b6c11Aa","doi-asserted-by":"crossref","unstructured":"Witkamp AJ, de Bree E, Kaag MM, van Slooten GW, van Coevorden F, Zoetmulder FA. Extensive surgical cytoreduction and intraoperative hyperthermic intraperitoneal chemotherapy in patients with pseudomyxoma peritonei. Br J Surg. 2001;88:458\u201363.10.1046\/j.1365-2168.2001.01701.x11260116","DOI":"10.1046\/j.1365-2168.2001.01701.x"},{"key":"2025120909201194912_j_pp-2018-0122_ref_012_w2aab3b7b1b1b6b1ab1b6c12Aa","doi-asserted-by":"crossref","unstructured":"Kusamura S, Baratti D, Virz\u00ec S, Bonomi S, Iusco DR, Grassi A, et al. Learning curve for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in peritoneal surface malignancies: analysis of two centres. J Surg Oncol. 2013;107:312\u201319.10.1002\/jso.2323122926536","DOI":"10.1002\/jso.23231"},{"key":"2025120909201194912_j_pp-2018-0122_ref_013_w2aab3b7b1b1b6b1ab1b6c13Aa","doi-asserted-by":"crossref","unstructured":"Kusamura S, Baratti D, Deraco M. Multidimensional analysis of the learning curve for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in peritoneal surface malignancies. Ann Surg. 2012;255:348\u201356.2220258410.1097\/SLA.0b013e3182436c28","DOI":"10.1097\/SLA.0b013e3182436c28"},{"key":"2025120909201194912_j_pp-2018-0122_ref_014_w2aab3b7b1b1b6b1ab1b6c14Aa","doi-asserted-by":"crossref","unstructured":"Smeenk RM, Verwaal VJ, Zoetmulder FA. Learning curve of combined modality treatment in peritoneal surface disease. Br J Surg. 2007;94:1408\u201314.1763167810.1002\/bjs.5863","DOI":"10.1002\/bjs.5863"},{"key":"2025120909201194912_j_pp-2018-0122_ref_015_w2aab3b7b1b1b6b1ab1b6c15Aa","doi-asserted-by":"crossref","unstructured":"Howell SB, Zimm S, Markman M, Abramson IS, Cleary S, Lucas WE, et al. Long-term survival of advanced refractory ovarian carcinoma patients with small-volume disease treated with intraperitoneal chemotherapy. J Clin Oncol. 1987;5:1607\u201312. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/244362210.1200\/JCO.1987.5.10.16072443622","DOI":"10.1200\/JCO.1987.5.10.1607"},{"key":"2025120909201194912_j_pp-2018-0122_ref_016_w2aab3b7b1b1b6b1ab1b6c16Aa","doi-asserted-by":"crossref","unstructured":"Elias D, Gilly F, Quenet F, Bereder JM, Sid\u00e9ris L, Mansvelt B, et al. Pseudomyxoma peritonei: a French multicentric study of 301 patients treated with cytoreductive surgery and intraperitoneal chemotherapy. Eur J Surg Oncol. 2010;36:456\u201362.2022723110.1016\/j.ejso.2010.01.006","DOI":"10.1016\/j.ejso.2010.01.006"},{"key":"2025120909201194912_j_pp-2018-0122_ref_017_w2aab3b7b1b1b6b1ab1b6c17Aa","unstructured":"Core Team R. R: A language and environment for statistical computing. https:\/\/www.r-project.org\/."},{"key":"2025120909201194912_j_pp-2018-0122_ref_018_w2aab3b7b1b1b6b1ab1b6c18Aa","doi-asserted-by":"crossref","unstructured":"Teo MC, Tan GH, Tham CK, Lim C, Soo KC. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in Asian patients: 100 consecutive patients in a single institution. Ann Surg Oncol. 2013;20:2968\u201374.10.1245\/s10434-013-2947-0","DOI":"10.1245\/s10434-013-2947-0"}],"container-title":["Pleura and Peritoneum"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.degruyter.com\/view\/journals\/pp\/3\/4\/article-20180122.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/pp-2018-0122\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/pp-2018-0122\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T21:13:55Z","timestamp":1775250835000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/pp-2018-0122\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,20]]},"references-count":18,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2018,10,20]]},"published-print":{"date-parts":[[2018,12,19]]}},"alternative-id":["10.1515\/pp-2018-0122"],"URL":"https:\/\/doi.org\/10.1515\/pp-2018-0122","relation":{},"ISSN":["2364-768X","2364-7671"],"issn-type":[{"value":"2364-768X","type":"electronic"},{"value":"2364-7671","type":"print"}],"subject":[],"published":{"date-parts":[[2018,10,20]]},"article-number":"20180122"}}